Stock OSUR ORASURE TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials OraSure Technologies, Inc.

Equities

OSUR

US68554V1089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
5.32 USD +1.14% Intraday chart for OraSure Technologies, Inc. +0.76% -35.12%
Feb. 27 Transcript : OraSure Technologies, Inc., 2023 Earnings Call, Feb 27, 2024
Feb. 27 Earnings Flash (OSUR) ORASURE TECHNOLOGIES Posts Q4 Revenue $75.9M, vs. Street Est of $74.3M MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 495.7 759.3 626 350 602.6 407 - -
Enterprise Value (EV) 1 495.7 551.3 475.9 251.7 602.6 130.4 407 407
P/E ratio 29.7 x -48.1 x -27.2 x -19.3 x 11.4 x -44.9 x -22.2 x -
Yield - - - - - - - -
Capitalization / Revenue 3.21 x 4.42 x 2.68 x 0.9 x 1.49 x 2.13 x 2.44 x 2.2 x
EV / Revenue 3.21 x 3.21 x 2.04 x 0.65 x 1.49 x 0.68 x 2.44 x 2.2 x
EV / EBITDA 30.6 x 122 x 319 x 6.8 x 6.38 x 90.7 x 43.9 x 14.2 x
EV / FCF 1,012 x -26.4 x -5.7 x -2.27 x 4.59 x 5.93 x - -
FCF Yield 0.1% -3.79% -17.5% -44.1% 21.8% 16.9% - -
Price to Book 1.61 x 1.79 x 1.65 x 0.96 x - 1 x 0.93 x -
Nbr of stocks (in thousands) 61,726 71,733 72,038 72,622 73,484 76,510 - -
Reference price 2 8.030 10.58 8.690 4.820 8.200 5.320 5.320 5.320
Announcement Date 2/19/20 3/1/21 2/23/22 2/14/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 154.6 171.7 233.7 387.5 405.5 191.4 166.6 184.6
EBITDA 1 16.19 4.537 1.494 37.03 94.51 1.437 9.265 28.7
EBIT 1 8.462 -5.177 -10.16 -22.96 73.58 -14.56 -27.8 -
Operating Margin 5.47% -3.01% -4.35% -5.92% 18.15% -7.61% -16.69% -
Earnings before Tax (EBT) 1 21.33 -3.524 -9.292 -16.48 56.26 -8.246 -21.12 -
Net income 1 16.66 -14.92 -23 -17.94 53.66 -9.355 -18.25 -
Net margin 10.77% -8.69% -9.84% -4.63% 13.23% -4.89% -10.95% -
EPS 2 0.2700 -0.2200 -0.3200 -0.2500 0.7200 -0.1184 -0.2400 -
Free Cash Flow 1 0.49 -20.87 -83.5 -111.1 131.3 22 - -
FCF margin 0.32% -12.15% -35.73% -28.68% 32.38% 11.49% - -
FCF Conversion (EBITDA) 3.03% - - - 138.9% 1,530.96% - -
FCF Conversion (Net income) 2.94% - - - 244.67% - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/19/20 3/1/21 2/23/22 2/14/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 53.92 63.57 67.71 80.23 116.5 123.1 155 85.44 89.19 75.88 52.27 53.73 41.98 42.73 33.41
EBITDA 1 -10.06 -6.192 -12.3 -6.652 4.459 22.26 33.23 10.09 23.93 17.19 3.466 4.009 -3.544 -3.904 -0.1
EBIT 1 -13.01 -9.371 -15.98 -21.29 0.875 13.44 24.32 -6.429 10.89 13.62 -0.748 -1.663 -5.784 -6.369 -7.217
Operating Margin -24.14% -14.74% -23.6% -26.53% 0.75% 10.92% 15.69% -7.52% 12.21% 17.95% -1.43% -3.09% -13.78% -14.9% -21.6%
Earnings before Tax (EBT) 1 -12.91 -8.928 -16.03 -19.97 4.13 15.4 26.99 -4.962 13.51 20.72 0.7195 -0.0875 -4.168 -4.71 -7.806
Net income 1 -15.02 -10.39 -19.97 -18.8 5.273 15.56 27.22 -4.796 11.16 20.07 0.6785 0.2935 -3.31 -3.828 -6.527
Net margin -27.85% -16.35% -29.49% -23.43% 4.53% 12.64% 17.56% -5.61% 12.51% 26.45% 1.3% 0.55% -7.88% -8.96% -19.54%
EPS 2 -0.2100 -0.1400 -0.2800 -0.2600 0.0700 0.2100 0.3700 -0.0700 0.1500 0.2700 -0.009270 -0.008000 -0.0510 -0.0522 -0.0850
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/3/21 2/23/22 5/10/22 8/9/22 11/8/22 2/14/23 5/10/23 8/3/23 11/7/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - 208 150 98.3 - 277 - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 0.49 -20.9 -83.5 -111 131 22 - -
ROE (net income / shareholders' equity) 5.64% -4.54% -5.9% 6.72% - -0.06% 1.61% 2.98%
ROA (Net income/ Total Assets) 2.58% -3.99% -5.02% 5.52% 16.7% 0.36% - -
Assets 1 645.3 374.3 457.7 -325.1 320.5 -2,606 - -
Book Value Per Share 2 4.980 5.900 5.280 5.000 - 5.330 5.700 -
Cash Flow per Share - - - - - - - -
Capex 1 9.31 26.7 48.1 63.9 10.3 8 8 -
Capex / Sales 6.02% 15.53% 20.59% 16.49% 2.54% 4.18% 4.8% -
Announcement Date 2/19/20 3/1/21 2/23/22 2/14/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for OraSure Technologies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
5.32 USD
Average target price
7.55 USD
Spread / Average Target
+41.92%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ORASURE TECHNOLOGIES, INC. Stock OraSure Technologies, Inc.
-35.12% 407M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. OSUR Stock
  4. Financials OraSure Technologies, Inc.